Huntington’s disease is a rare, inherited neurodegenerative disorder that affects the brain and drastically decreases quality ...
Just as life pulsates in big vibrant cities, it also prospers in crowded environments inside cells. The interior of cells is densely packed with biomolecules like proteins and nucleic acids. How is ...
An experimental gene therapy has slowed the progression of Huntington’s disease by 75 percent, according to results reported by the biotechnology company uniQure this week. Huntington’s is an ...
This is clearly good news, though there is no claim of a cure and if it can be turned into a treatment, that will surely be an expensive one. But uniQure estimates that 100,000 people in America alone ...
One of the most devastating diseases finally has a treatment that can slow its progression and transform lives, tearful ...
Levels of iron in the brain could be a warning sign of future Alzheimer’s disease, a new study suggests. High levels of the chemical element have been shown to increase brain toxins and trigger ...
Automatic differentiation of Parkinson’s disease motor subtypes based on deep learning and radiomics
Objective: Parkinson’s disease (PD) is a common neurodegenerative disorder, and the early and accurate differentiation of its motor subtypes is of significant importance for clinical diagnosis and ...
Royalty-free licenses let you pay once to use copyrighted images and video clips in personal and commercial projects on an ongoing basis without requiring additional payments each time you use that ...
ROCHESTER — Nucleus RadioPharma, the downtown Rochester-based, Mayo Clinic-co-founded radioactive drug maker, has a new chief executive officer. Dr. Stephen Hahn is a physician, former chief medical ...
Johnson & Johnson will spend $2 billion over the next 10 years to operate a 160,000-square-foot manufacturing facility at Fujifilm Biotechnologies' massive biomanufacturing campus in Holly Springs, ...
Hahn brings a rare combination of regulatory experience, clinical expertise and operational leadership to unlock the full potential of radiopharmaceuticals. ROCHESTER, Minn.--(BUSINESS WIRE)--Nucleus ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback